Page 2 - Contribuciones
P. 2

J. F. Villa-Manríquez, J. Castro-Ramos, F. Gutiérrez-Delgado, M. A. Lopéz-Pacheco, A. E. Villanueva-Luna3.
       Raman spectroscopy and PCA-SVM as a non-invasive diagnostic tool to identify and classify qualitatively glycated
       hemoglobin levels in vivo.
       http://onlinelibrary.wiley.com/doi/10.1002/jbio.201600169/full
       J. Biophotonics 1–6 (2016) / DOI 10.1002/jbio.201600169





          M. Schuler, J. C.-H., Yang, K. Park et al. Afatinib beyond
         progression in patients with non-small-cell lung cancer
         following chemotherapy, erlotinib/gefitinib and afatinib:
         phase III randomized LUX-Lung 5 trial. Ann Oncol. 2016;
         27(3): 417–423.
         https://academic.oup.com/annonc/issue/27/3
                                                            F. Gutierrez Delgado. Early Cancer Detection:
                                                            Current status and emerging strategies.
                                                            Practical Oncology 2016; 17(1): 11-14

                                                            http://practical-oncology.ru/assets/articles/40.pdf














         Wilke H, Muro K, Van Cutsem E, et al, for the RAINBOW Study Group. Ramucirumab plus paclitaxel
         versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal
         junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. Lancet Oncol 2014; 15
         (11): 1224–1235

         http://ascopubs.org/doi/abs/10.1200/jco.2014.32.3_suppl.lba7
         http://www.thelancet.com/cms/attachment/2022766001/2043206992/mmc1.pdf
   1   2   3   4   5   6   7